NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.

Published

Journal Article

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.

Full Text

Duke Authors

Cited Authors

  • Kumar, SK; Callander, NS; Hillengass, J; Liedtke, M; Baljevic, M; Campagnaro, E; Castillo, JJ; Chandler, JC; Cornell, RF; Costello, C; Efebera, Y; Faiman, M; Garfall, A; Godby, K; Holmberg, L; Htut, M; Huff, CA; Kang, Y; Landgren, O; Malek, E; Martin, T; Omel, J; Raje, N; Sborov, D; Singhal, S; Stockerl-Goldstein, K; Tan, C; Weber, D; Johnson-Chilla, A; Keller, J; Kumar, R

Published Date

  • October 1, 2019

Published In

Volume / Issue

  • 17 / 10

Start / End Page

  • 1154 - 1165

PubMed ID

  • 31590151

Pubmed Central ID

  • 31590151

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2019.0049

Language

  • eng

Conference Location

  • United States